Evolva Holding en liquidation Ltd - Company Profile

Powered by

All the data and insights you need on Evolva Holding en liquidation Ltd in one report.

  • Save hours of research time and resources with
    our up-to-date Evolva Holding en liquidation Ltd Strategy Report

  • Understand Evolva Holding en liquidation Ltd position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Evolva Holding en liquidation Ltd: Segment Analysis

Business Description

Evolva Holding en liquidation Ltd (Evolva), formerly Evolva Holding SA, is a biotechnology company that discovers and develops health ingredients, Flavors and Fragrances. The company’s ingredients includes resveratrol, stevia, nootkatone, vanillin, and valencene. Its businesses span industries such as Flavors and Fragrances, Health Ingredients and Health Protection. The company offers its products under various brand names including Veri-te Resveratrol, NootkaShield and EverSweet Stevia. It has business presence in Switzerland, the US Denmark, and the rest of the world.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

R&D Overview

Evolva's R&D activities focus on product and production process development, and commercialization of products. It operates an R&D facility at Reinach, Switzerland. Evolva maintains a continuous search for novel and distinctive ideas to expand its portfolio of ingredient product candidates. The selection and evaluation process for new compounds follows a dedicated screening approach, incorporating several essential factors. These factors include the stage of R&D development and feasibility, competitive cost and pricing positioning, market demand, alignment with prominent ingredient trends, complementarity with existing products, adherence to regulatory requirements, and the envisioned go-to-market strategy. In FY2022, the company incurred expenses of CHF23.5 million on R&D.




Geographical Segments

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Performance

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Gain a 360-degree view of Evolva Holding en liquidation Ltd and make more informed decisions for your business Gain a 360-degree view of Evolva Holding en liquidation Ltd and make more informed decisions for your business Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code